瑞穗分析师看好生物科技中小盘板块，力推Immix Biopharma

17 9 月, 2026

One Min Read

1 Views

Last Update: 17 9 月, 2026

Written By

Other Articles

Previous

Goldman says the economy is rewarding capital ownership over labor — and most Americans don’t own enough of it to benefit

Next

Anthropic merges its Claude chat and agentic Cowork products into a single AI assistant as part of a push to build an AI superapp

Related Posts

先消灭低价股！

1 Min Read

假期市场思考：A股还是美股？

1 Min Read

香港证券两日成交额破百亿！港股仍有市场？

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept